PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $239,000 | -0.8% | 17,000 | +11.8% | 0.02% | -13.0% |
Q4 2018 | $241,000 | +28.2% | 15,200 | +52.0% | 0.02% | +53.3% |
Q3 2018 | $188,000 | -85.6% | 10,000 | -89.5% | 0.02% | -90.1% |
Q2 2016 | $1,310,000 | -35.6% | 95,360 | -35.5% | 0.15% | -38.9% |
Q1 2016 | $2,034,000 | -99.9% | 147,908 | -23.6% | 0.25% | +4.2% |
Q4 2015 | $1,962,090,000 | +100778.7% | 193,500 | 0.0% | 0.24% | -10.9% |
Q3 2015 | $1,945,000 | -32.2% | 193,500 | 0.0% | 0.27% | -26.3% |
Q2 2015 | $2,870,000 | -10.6% | 193,500 | 0.0% | 0.36% | -9.8% |
Q1 2015 | $3,210,000 | +9.5% | 193,500 | 0.0% | 0.40% | +6.1% |
Q4 2014 | $2,932,000 | +7.0% | 193,500 | 0.0% | 0.38% | -1.6% |
Q3 2014 | $2,740,000 | 0.0% | 193,500 | 0.0% | 0.38% | +4.4% |
Q2 2014 | $2,740,000 | -2.5% | 193,500 | +17.9% | 0.37% | -4.7% |
Q1 2014 | $2,811,000 | +2.0% | 164,106 | -12.6% | 0.38% | +3.8% |
Q4 2013 | $2,757,000 | +5.6% | 187,694 | -4.8% | 0.37% | -8.8% |
Q3 2013 | $2,612,000 | +15.8% | 197,100 | -6.2% | 0.41% | +2.5% |
Q2 2013 | $2,256,000 | – | 210,090 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
22NW, LP | 274,418 | $1,089,439 | 0.78% |
WEALTH EFFECTS LLC | 40,701 | $161,582 | 0.08% |
Cannell Capital | 74,794 | $296,932 | 0.07% |
SANTA MONICA PARTNERS LP | 20,000 | $79 | 0.06% |
RBF Capital, LLC | 144,231 | $572,597 | 0.04% |
WEDBUSH SECURITIES INC | 42,414 | $168 | 0.01% |
Ancora Advisors LLC | 78,373 | $311,141 | 0.01% |
Your Advocates Ltd., LLP | 1,400 | $5,558 | 0.00% |
CRAWFORD INVESTMENT COUNSEL INC | 32,098 | $127,428 | 0.00% |
Renaissance Technologies | 273,663 | $1,086 | 0.00% |